Holen Sie sich die Stockscreener-App
114.47
0.04%
-0.0401
Arcellx Inc Aktie (ACLX) Neueste Nachrichten
Gilead Sciences at Barclays: CFO touts YEZTUGO launch, Arcellx deal and “long cycle” growth - MarketBeat
Arcellx and Aardvark Therapeutics Compared - National Today
This $64 Million Biotech Exit Seemingly Missed a 77% One-Day Surge on Gilead Takeover Deal - The Motley Fool
Arcellx, Inc. $ACLX Position Lifted by HighVista Strategies LLC - MarketBeat
Bamco Inc. NY Increases Stake in Arcellx, Inc. - National Today
Bamco Inc. NY Has $45.17 Million Stake in Arcellx, Inc. $ACLX - MarketBeat
Gilead Sciences to buy Arcellx in deal valued at $7.8 billion - MSN
Integral Health Asset Management LLC Invests $12.32 Million in Arcellx, Inc. $ACLX - MarketBeat
Arcellx Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Arcellx, Inc.ACLX - Business Wire
Gilead Sciences to buy Arcellx in deal worth up to $7.8B - MSN
Shareholder Alert: The Ademi Firm Investigates Whether Arcellx Inc. Is Obtaining a Fair Price for Its Public Shareholders - 富途牛牛
Will GILD's Move to Acquire ACLX Boost Its Cell Therapy Franchise? - sharewise.com
Short Interest in Arcellx, Inc. (NASDAQ:ACLX) Declines By 38.0% - MarketBeat
Victory Capital Management Inc. Has $14.13 Million Stock Position in Arcellx, Inc. $ACLX - MarketBeat
Gilead’s US$7.8b Arcellx Deal Deepens Cell Therapy Diversification - simplywall.st
Gilead to Acquire Arcellx, Inc. (ACLX) for Up to $7.8 billion - Finviz
Are ACLX, DBRG, AVO, CVGW Obtaining Fair Deals for their Shareholders? - Sahm
Arcellx set to report earnings amid $7.8B Gilead deal - Investing.com
American Century Companies Inc. Has $33.82 Million Position in Arcellx, Inc. $ACLX - MarketBeat
Gilead to buy US biotech Arcellx for up to $7.8 billion - MSN
Blue Owl Capital Holdings LP Buys Shares of 26,823 Arcellx, Inc. $ACLX - MarketBeat
Arcellx (NASDAQ: ACLX) backs $115 cash plus $5 CVR tied to $6B anito-cel sales - Stock Titan
(ACLX) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Arcellx Inc share price - Capital.com
Gilead Sciences stock forecast for 2030: Can $7.8B Arcellx deal push GILD to $220 with no patent cliff until 2036? - Traders Union
Arcellx, Inc. (NASDAQ:ACLX) Receives Average Rating of "Hold" from Analysts - MarketBeat
Halper Sadeh LLC is Investigating Whether ACLX, VRE, EHAB are Obtaining Fair Deals for their Shareholders - GlobeNewswire
Top 2 Health Care Stocks That May Crash This QuarterArcellx (NASDAQ:ACLX), Anika Therapeutics (NASDAQ:ANIK) - Benzinga
Multiple Myeloma Market 2026: Gilead Sciences Acquires Arcellx for $7.8B to Control CAR-T Therapy - openPR.com
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Arcellx Inc (ACLX), Alkermes (ALKS) and Progyny (PGNY) - The Globe and Mail
Arcellx Inc stock hits all-time high at 114.27 USD - Investing.com Australia
Are ACLX, VRE, LSF Obtaining Fair Deals for their Shareholders? - Stock Titan
Gilead Sciences’ Yeztugo Revenue Is Set to Jump 400%: Here’s What Comes Next - TIKR.com
Arcellx (NASDAQ:ACLX) Hits New 52-Week HighStill a Buy? - MarketBeat
Arcellx Inc stock hits all-time high at 114.27 USD By Investing.com - Investing.com UK
Arcellx, Inc. (ACLX) Stock Analysis: Navigating Biotech’s Cutting Edge with Strategic Alliances - DirectorsTalk Interviews
Cowen Downgrades Arcellx, Inc. (ACLX) to Hold on March 2, 2026 - Meyka
ACLX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Gilead Sciences Arcellx Deal Deepens Oncology Bet And Tests HIV Reliance - Yahoo Finance
Arcellx stock rating cut to Hold by TD Cowen on Gilead deal - Investing.com India
Arcellx President Sells $10 Million Worth of Shares After Acquisition Announcement - The Globe and Mail
Arcellx President Sells $10M Worth of Shares After Acquisition Announcement - The Globe and Mail
TD Cowen Downgrades Arcellx to Hold From Buy - marketscreener.com
Citigroup Inc. Sells 13,427 Shares of Arcellx, Inc. $ACLX - MarketBeat
TD Asset Management Inc Buys 129,248 Shares of Arcellx, Inc. $ACLX - MarketBeat
Vanguard Group Inc. Sells 37,798 Shares of Arcellx, Inc. $ACLX - MarketBeat
Insider Selling: Arcellx (NASDAQ:ACLX) Insider Sells 89,916 Shares of Stock - MarketBeat
Arcellx CEO Elghandour sells $10.2 million in ACLX stock - Investing.com
Tax-withholding sale by Arcellx (NASDAQ: ACLX) director Elghandour - Stock Titan
Arcellx, Inc. Hits Day High with 77.43% Surge in Stock Price - Markets Mojo
E-Trade Financial (NASDAQ: ACLX) files Form 144 listing 164,548 RSU shares - Stock Titan
Taxation With Representation: Linklaters, Wilson Sonsini - Law360
Gilead Sciences Inc Stock Moved Up by 3.72% on Feb 27: What Investors Need To Know - TradingKey
Arcellx, Inc. Experiences Evaluation Revision Amid Strong Market Performance and Volatility - Markets Mojo
Arcellx (NASDAQ:ACLX) Announces Earnings Results, Meets Estimates - MarketBeat
0.09%
0.18%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):